{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:50:55Z","timestamp":1788497455052,"version":"build-2803163510"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T00:00:00Z","timestamp":1499990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0181082","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T13:42:14Z","timestamp":1500039734000},"page":"e0181082","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9198-5137","authenticated-orcid":true,"given":"Andreas Austgulen","family":"Westin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Brekke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Espen","family":"Molden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirik","family":"Skogvoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Spigset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1007\/s10995-016-2038-5","article-title":"Use of antidepressants during pregnancy?: What to consider when weighing treatment with antidepressants against untreated depression","volume":"20","author":"M Muzik","year":"2016","journal-title":"Maternal and child health journal"},{"issue":"445","key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/acps.12479","article-title":"Use of psychotropic drugs during pregnancy and breast-feeding","author":"ER Larsen","year":"2015","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40263-016-0338-3","article-title":"Safety of selective serotonin reuptake inhibitors in pregnancy: A review of current evidence","volume":"30","author":"S Alwan","year":"2016","journal-title":"CNS drugs"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","article-title":"Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach","volume":"44","author":"GD Anderson","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fphar.2014.00065","article-title":"Physiologic and pharmacokinetic changes in pregnancy","volume":"5","author":"MM Costantine","year":"2014","journal-title":"Front Pharmacol"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cpt.382","article-title":"Pregnancy-related pharmacokinetic changes","volume":"100","author":"Y Tasnif","year":"2016","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"e1002160","DOI":"10.1371\/journal.pmed.1002160","article-title":"Pregnancy-associated changes in pharmacokinetics: A systematic review","volume":"13","author":"G Pariente","year":"2016","journal-title":"PLoS Med"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1176\/ajp.150.10.1541","article-title":"Tricyclic dose requirements across pregnancy","volume":"150","author":"KL Wisner","year":"1993","journal-title":"Am J Psychiatry"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00004714-199602000-00015","article-title":"Pregnancy and psychotropic medication: changes in blood levels","volume":"16","author":"LL Altshuler","year":"1996","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"ref10","first-page":"243","article-title":"Effects of the postpartum period on nortriptyline pharmacokinetics","volume":"33","author":"KL Wisner","year":"1997","journal-title":"Psychopharmacol Bull"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1520-6394(2000)11:2<51::AID-DA1>3.0.CO;2-R","article-title":"Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications","volume":"11","author":"A Hostetter","year":"2000","journal-title":"Depress Anxiety"},{"issue":"4 Suppl","key":"ref12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1359786806066054","article-title":"Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities","volume":"20","author":"CL DeVane","year":"2006","journal-title":"J Psychopharmacol"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mcp.2002.126181","article-title":"Citalopram in pregnancy and lactation","volume":"72","author":"T Heikkinen","year":"2002","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0009-9236(02)17634-X","article-title":"Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation","volume":"73","author":"T Heikkinen","year":"2003","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2125.2005.02538.x","article-title":"Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding","volume":"61","author":"J Kim","year":"2006","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/JCP.0b013e31815a57d8","article-title":"Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum","volume":"27","author":"CM Klier","year":"2007","journal-title":"J Clin Psychopharmacol"},{"issue":"11","key":"ref17","first-page":"34","article-title":"Optimisation of pharmacotherapy for depression during pregnancy. Pilot study for evaluation of existing paroxetine therapy","volume":"142","author":"J Brogtrop","year":"2007","journal-title":"Pharm Weekbl"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/JCP.0b013e31818d2048","article-title":"Pharmacokinetics of sertraline across pregnancy and postpartum","volume":"28","author":"MP Freeman","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4088\/JCP.v69n0419","article-title":"Changes in antidepressant metabolism and dosing across pregnancy and early postpartum","volume":"69","author":"DK Sit","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2165\/11318050-000000000-00000","article-title":"Effect of cytochrome P450 2D6 genotype on maternal paroxetine plasma concentrations during pregnancy","volume":"48","author":"FF Ververs","year":"2009","journal-title":"Clin Pharmacokinet"},{"issue":"1\u20133","key":"ref21","first-page":"93","article-title":"Changes in antidepressant metabolism in pregnancy evidenced by metabolic ratios in hair: a novel approach","volume":"196","author":"L O'Brien","year":"2010","journal-title":"Forensic Sci Int"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/JCP.0b013e3181e7be23","article-title":"Disposition of chiral and racemic fluoxetine and norfluoxetine across childbearing","volume":"30","author":"D Sit","year":"2010","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00737-014-0421-z","article-title":"Returning to tricyclic antidepressants for depression during childbearing: clinical and dosing challenges","volume":"17","author":"LM Osborne","year":"2014","journal-title":"Archives of women's mental health"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/jcpt.12188","article-title":"Concentrations of venlafaxine and its main metabolite O-desmethylvenlafaxine during pregnancy","volume":"39","author":"PG ter Horst","year":"2014","journal-title":"J Clin Pharm Ther"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00228-015-1944-6","article-title":"Pharmacokinetics of clomipramine during pregnancy","volume":"71","author":"PG Ter Horst","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"issue":"21","key":"ref26","first-page":"2382","article-title":"Therapeutic drug monitoring (TDM) repertoire in Norway","volume":"132","author":"AA Westin","year":"2012","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/j.1600-0412.2000.079006435.x","article-title":"The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30 years","volume":"79","author":"LM Irgens","year":"2000","journal-title":"Acta obstetricia et gynecologica Scandinavica"},{"key":"ref28","unstructured":"WHO Collaborative Centre for Drug Statistics Methodology. ATC\/DDD Index 2016 [cited 2016 Dec]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.whocc.no\/atc_ddd_index\/\" xlink:type=\"simple\">http:\/\/www.whocc.no\/atc_ddd_index\/<\/ext-link>."},{"key":"ref29","unstructured":"Drug interaction database for Norwegian clinicians. [cited 2016 Dec]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/interaksjoner.no\/\" xlink:type=\"simple\">http:\/\/interaksjoner.no\/<\/ext-link>."},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/FTD.0b013e31819114ea","article-title":"Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database","volume":"31","author":"M Reis","year":"2009","journal-title":"Ther Drug Monit"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/FTD.0000000000000169","article-title":"Therapeutic drug monitoring of selective serotonin reuptake inhibitors in elderly patients","volume":"37","author":"M Hermann","year":"2015","journal-title":"Ther Drug Monit"},{"key":"ref32","article-title":"Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics","author":"L Brunton","year":"2011"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00003088-200746040-00002","article-title":"The clinical pharmacokinetics of escitalopram","volume":"46","author":"N Rao","year":"2007","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"C Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"ref35","first-page":"143","article-title":"Metabolism of the newest antidepressants: comparisons with related predecessors","volume":"7","author":"S Caccia","year":"2004","journal-title":"IDrugs: the investigational drugs journal"},{"issue":"5","key":"ref36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1517\/14656566.9.5.787","article-title":"Paroxetine","volume":"9","author":"SW Tang","year":"2008","journal-title":"Expert Opin Pharmacother"},{"issue":"24","key":"ref37","first-page":"2832","article-title":"Cytochrome P-450 3A4\u2014the most important arena for drug interactions in the body","volume":"128","author":"O Spigset","year":"2008","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JCP.0000000000000087","article-title":"Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring","volume":"34","author":"KM Deligiannidis","year":"2014","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ajog.2004.08.030","article-title":"Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy","volume":"192","author":"TS Tracy","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1742-7843.2005.pto_194.x","article-title":"Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine","volume":"97","author":"MG Scordo","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/dmd.104.002428","article-title":"Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study","volume":"33","author":"RS Obach","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.clpt.2004.08.011","article-title":"The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum","volume":"76","author":"RP van Heeswijk","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"796590","DOI":"10.1155\/2012\/796590","article-title":"Adherence with drug therapy in pregnancy","volume":"2012","author":"D Matsui","year":"2012","journal-title":"Obstet Gynecol Int"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/FTD.0000000000000101","article-title":"Effect of proton pump inhibitors on the serum concentrations of the selective serotonin reuptake inhibitors citalopram, escitalopram, and sertraline","volume":"37","author":"C Gjestad","year":"2015","journal-title":"Ther Drug Monit"},{"issue":"Suppl 7","key":"ref45","doi-asserted-by":"crossref","first-page":"S437","DOI":"10.1093\/cid\/ciu709","article-title":"Designing drug trials: considerations for pregnant women","volume":"59","author":"JS Sheffield","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ajog.2015.05.047","article-title":"Should pregnant women be included in phase IV clinical drug trials?","volume":"213","author":"GG Briggs","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"ref47","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1586\/14737175.2015.1083422","article-title":"Management of epilepsy during pregnancy","volume":"15","author":"PE Voinescu","year":"2015","journal-title":"Expert Rev Neurother"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0191508","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T00:00:00Z","timestamp":1516060800000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0181082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T04:08:23Z","timestamp":1569816503000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0181082"}},"subtitle":[],"editor":[{"given":"Judith","family":"Homberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":47,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0181082","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0191508","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,14]]}}}